ECP-1014

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameECP-1014
Drug Alias NameECP-1014GIBH-1014
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenase-2 inhibitors
TargetsCyclooxygenase-2
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesGuangzhou Institute Of Biomedicine And Health, Chinese Academy Of Sciences
China Registration ClassN/A

Develop Information

Active CompaniesEuclises Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A